| Followers | 40 |
| Posts | 3648 |
| Boards Moderated | 0 |
| Alias Born | 07/23/2003 |
Wednesday, February 24, 2021 10:28:12 PM
JL: Good shopping day yesterday.
As long as you didn't look at your main portfolio. :)
The FED will do nothing that will interfere with keeping the part of America that has investments OK even know some inflation fears. Do not mess with the markets. They have enough to worry about.
They will lay low.
RE: 70's: Coming out of high school in the late 70's inflation, my first CD had an interest rate of 16%! I do not see us getting there any time soon :)
Meanwhile, Getting the word out about BNGO can not come fast enough. :)
I agree with you about not only the health, but the economic consequences.
What I think is wonderful is the fact that Patients will not have to fight Insurance companies because of the cost of this testing. This test has a cost less than my last round of blood tests!
Affordable testing that can prevent future costs. Win win.
As long as you didn't look at your main portfolio. :)
The FED will do nothing that will interfere with keeping the part of America that has investments OK even know some inflation fears. Do not mess with the markets. They have enough to worry about.
They will lay low.
RE: 70's: Coming out of high school in the late 70's inflation, my first CD had an interest rate of 16%! I do not see us getting there any time soon :)
Meanwhile, Getting the word out about BNGO can not come fast enough. :)
I agree with you about not only the health, but the economic consequences.
What I think is wonderful is the fact that Patients will not have to fight Insurance companies because of the cost of this testing. This test has a cost less than my last round of blood tests!
Affordable testing that can prevent future costs. Win win.
Recent BNGO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 12:00:17 PM
- Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures • GlobeNewswire Inc. • 05/28/2026 12:00:00 PM
- Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia • GlobeNewswire Inc. • 05/26/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 10:16:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 10:15:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:29:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:09:36 PM
- Bionano Reports First Quarter 2026 Results and Provides a Business Update • GlobeNewswire Inc. • 05/13/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:03:04 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/08/2026 08:02:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 08:30:53 PM
- Bionano Announces Leadership Transition • GlobeNewswire Inc. • 05/06/2026 08:30:00 PM
- Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 • GlobeNewswire Inc. • 05/05/2026 12:00:00 PM
- Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 • GlobeNewswire Inc. • 04/29/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 08:06:01 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:04:43 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:02:51 PM
- Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma • GlobeNewswire Inc. • 04/02/2026 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/25/2026 08:28:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 08:08:58 PM
- Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 • GlobeNewswire Inc. • 03/23/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 08:04:52 PM
- Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale • GlobeNewswire Inc. • 02/27/2026 01:00:00 PM
- 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
